8:15 am Online Registration & Virtual Coffee Networking

8:45 am Chair’s Opening Remarks

Achieveing Seamless Clinical Integration

9:00 am Considerations in Managing the Chain of Identity for Seamless and Safe Delivery of Cell Therapies

• William Shingler Senior Director, Patient & Cell Management, Autolus Ltd

9:30 am Developing Integrated Systems for End-to-End Visibility and Product Tracking in the Cell Therapy Supply Chain

• Amol Thote Senior Director Cell Therapy Network Strategy & Supply Chain Management, Bayer

10:00 am Panel Discussion: Discussing Approaches to Cloud-Based Systems and Integrated Platforms for End-to-End Visibility with the End-User in Mind

• Amol Thote Senior Director Cell Therapy Network Strategy & Supply Chain Management, Bayer
• Neeraj Shah Global Clinical Supply Chain Excellence, Bristol-Myers Squibb
• Kawa Chiu Vice President of CMC Supply Chain , Lyell Immunopharma

10:30 am Morning Refreshments & Virtual Networking

Discussing Best Practices and Moving Towards Standard, Shared Processes

11:15 am Examining the Supply Chain to Identify Common Processes Across the Industry to Establish Supply Chain Standards and Support Product Quality

• George O’Sullivan Head of Supply Chain, Elevate Bio

11:45 am Panel Discussion: Can Cell Therapy Supply Chains be Standardized, and Developing Best Practice Guidelines for Efficiency at Scale and Better Patient Care

• Christopher Baldwin Supply Chain Director, Cell Therapy, GSK
• George O’Sullivan Head of Supply Chain, Elevate Bio
• Richard McFarland President, Standards Coordinating Body
• Jean Stanton Director Commercial Apheresis Operations, The Janssen Pharmaceutical Companies of Johnson & Johnson

12:30 pm Lunch & Workshop Session: Workshop Session: Scaling up Supply Chains to Meet Demand for Cell Immunotherapies

• David Boodey Supply Chain Manager, Adaptimmune Therapeutics

Minimizing Risk and Scaling Up

2:00 pm Developing a Risk-Based Approach to Raw Material Management for Effective CAR-T Clinical Development

• Emilie Gauthy Industrialization Manager, Celyad

2:30 pm Panel Discussion: Managing Risk in Uncertain Times Using Lessons Learnt from COVID-19 Disruption

• Albert Ribickas Supervisor, Cell Therapy Facility, Moffitt Cancer Center
• Reggie Foster Sr. Director of Labelling, Logistics, & Packaging, Kite: A Gilead Company
• David Boodey Supply Chain Manager, Adaptimmune Therapeutics

3:15 pm Afternoon Virtual Networking

Sourcing Materials and Facilities Management

4:00 pm Choosing High Quality Materials and Suppliers to Support Vein-to-Vein Supply Chains

• Vadim Klyushnichenko VP, Pharmaceutical Development and Quality, Cailbr at Scripps Research

4:30 pm Deciding When and What to Outsource and Managing Internal Facilities

• Shah Ahmad Associate Director Cell Therapy External Manufacturing & Strategic Sourcing, Celgene

5:00 pm Comparing Centralized vs. Point of Care Facilities Using Models and Simulations to Determine Which Model to Employ, and When?

• Ben Wang Executive Director of the Georgia Tech Manufacturing Institute, Georgia Institute of Technology
• Chelsea White Schneider National Chair in Transportation and Logistics, Georgia Institute of Technology

5:30 pm Chair’s Closing Remarks

5:45 pm Close of Summit